Home / TechnologyTechCrunchTechnologyTechCrunch·Jul 20, 2026·1 min readColossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuationThe de-extinction startup is looking to double or triple its previous valuation, according to the report.View original source — TechCrunch ↗ShareCopy linkShare on XShare on FacebookRelated storiesThe PunchTechnologyJul 21, 2026 · 1 minHow I was almost molested by my football coach, Peller recountsThe PunchSouth China Morning PostTechnologyJul 21, 2026 · 1 minTo win the chip war, China needs a multinational strategySouth China Morning PostThe Next WebTechnologyJul 21, 2026 · 1 minChina weighs export controls on its own AI models and chips, FT reportsThe Next WebTASSTechnologyJul 21, 2026 · 1 minFalling drone debris injures child in Russia’s Black Sea city of SochiTASS
The PunchTechnologyJul 21, 2026 · 1 minHow I was almost molested by my football coach, Peller recountsThe Punch
South China Morning PostTechnologyJul 21, 2026 · 1 minTo win the chip war, China needs a multinational strategySouth China Morning Post
The Next WebTechnologyJul 21, 2026 · 1 minChina weighs export controls on its own AI models and chips, FT reportsThe Next Web
TASSTechnologyJul 21, 2026 · 1 minFalling drone debris injures child in Russia’s Black Sea city of SochiTASS